Skip to main content
Premium Trial:

Request an Annual Quote

USA Today Says Venter and Collins Less Influential Than Oprah Winfrey; Stratagene Taps New VP; Strategic Dx Adds Director

NEW YORK (GenomeWeb News) — Francis Collins and J. Craig Venter have landed on USA Today’s 25th anniversary list of the 25 most influential people over the past 25 years for their contributions to mapping the human genome.
USA Today said that Collins’ and Venter’s work in mapping the genome earns them spots four and five, respectively. Those ranks place the biologists one spot ahead of Osama bin Laden and one spot behind Oprah Winfrey.

William Molnar has become vice president and general manager of the Stratagene Division at Agilent Technologies.
Molnar was vice president and general manager of EMD Chemicals’ lab business.

Strategic Diagnostics has elected Geoffrey Davis to its board of directors. Davis, who is taking over the spot left by the retiring Richard Defieux, is the founder of Abgenix and is currently CEO of Angelica Therapeutics. He also was on the faculty at the University of California, San Francisco, worked at the Howard Hughes Medical Institute, Repligen, and Cell Genesys

Hana Biosciences has appointed Steven Deitcher CEO and president, effective immediately. Deitcher formerly was vice president and chief medical scientist at Nuvelo. He also was head of hematology and coagulation medicine in the Department of Hematology/Oncology and director of research in the department of vascular medicine at The Cleveland Clinic Foundation. Deitcher started at Hana Biosciences in May 2007 as executive vice president of development and chief medical officer.  

Scienion appointed Timm Jessen as a member of its supervisory board. Jessen, who has been CSO of Evotec and worked at Hoechst and Sanofi-Aventis, is filling a slot left open by the outgoing Gerhard Steinkamp, who resigned in May.

Martin Leach recently left his life sciences post with government contractor Booz Allen Hamilton and has joined Merck as an executive director of IT for basic research and biomarkers. Before he joining Booz Allen, Leach was director of bioinformatics at Curagen.

Health Discovery has added Richard Caruso and Jimmy Woodward to its board.
Caruso is the founder of Integra Life Sciences, where he serves as chairman. He also founded the Provco Group, which funds entrepreneurs and businesses.
Woodward is senior vice president and chief financial officer of Flowers Foods, posts from which he will step down in mid September. Woodward was also a director at Keebler Foods and PRG-Schultz International.

Ulf Jonsson and Jim Richey have joined Plexera’s board of directors. Jonsson was one of the founders of Biacore, where he was CEO for four years. Richey co-founded Auguron Biosciences, where is CEO and president.
Plexara is a recently-created subsidiary of Lumera.

The California Healthcare Institute has elected Hans Bishop and Catherine Mackey to its board of directors.
Bishop is head of the Hematology/Cardiology Business Unit of Bayer HealthCare Pharmaceuticals and has worked at Chiron, Glaxo Wellcome, and SmithKline Beecham.
Mackey is senior vice president of Pfizer Global Research and Development and formerly worked at Monsanto and Dekalb.

RXi Pharmaceuticals chief financial officer James Warren plans to leave the company “to pursue other opportunities.” He will be replaced by Stephen DiPalma.
DiPalma was co-founder, president, and CFO of Catalyst Oncology, and has been CFO at Milkhaus Laboratory and Phytera.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.